Gharamti et al. have highlighted the importance of targeting pro-inflammatory cytokines in COVID-19, aligning with findings from Zawawi et al. and Jia et al., who identified elevated TNF-α levels as an independent risk factor for mortality in critically ill patients [2, 13, 44]. Here, TNF is linked to COVID-19.